As President Trump continues to make claims about a coronavirus vaccine becoming available before the 2020 election, North Carolina Democratic Senate candidate Cal Cunningham said he would 'ask a lot of questions' if a vaccine was approved so quickly.
Democratic U.S. Senate candidate Cal Cunningham speaks to supporters in March. North Carolina is among the most competitive Senate races in the country this fall as Cunningham challenges incumbent Thom Tillis.Democratic U.S. Senate candidate Cal Cunningham speaks to supporters in March. North Carolina is among the most competitive Senate races in the country this fall as Cunningham challenges incumbent Thom Tillis.
The debate moderator, David Crabtree of local TV station WRAL, then asked Cunningham again about his vaccine comments.Cunningham's skepticism comes as President Trump makes repeated claims that a COVID-19 vaccine could be available before the election. The president said in an interview on Fox News Tuesday that a vaccine would be available in"weeks," even as scientific officials and the pharmaceutical industry caution that it will be 2021 before one will be widely available.
After the debate, Republicans criticized Cunningham's answers as"outrageous" and"dangerous." Arkansas Sen. Tom Cotton said the Democrats are theFor Democrats, the issue of a vaccine approved by the Trump administration has been difficult to navigate.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer stock rockets as potential COVID-19 vaccine delivery by end of 2020Pfizer is among the stocks driving the rally in US futures after CEO&39;s optimistic announcement over vaccine.
Read more »
When will there be a COVID-19 vaccine and should you trust that it's safe?Americans want a COVID-19 vaccine—but worry that it could be rushed out before the election. Here's what the science says.
Read more »
Valneva to supply up to 190 million doses of COVID-19 vaccine to UKFrench vaccine maker Valneva said on Monday it would supply the UK with up to 190 million doses of its coronavirus vaccine candidate, VLA2001, over a five-year period.
Read more »
Exclusive: AstraZeneca COVID-19 vaccine trial in U.S. on hold until at least midweek - sourcesAstraZeneca's COVID-19 vaccine trial remains on hold in the United States pending a U.S. investigation into a serious side effect in Britain even as other trials of the vaccine resume, sources familiar with the details told Reuters.
Read more »
AstraZeneca's COVID-19 vaccine trial in the U.S. remains halted: reportU.S. trials of AstraZeneca Plc.'s undefined and Oxford University COVID-19 vaccine candidate will be on hold until at least midweek, pending a Federal Drug...
Read more »
AstraZeneca COVID-19 vaccine trials resume in BrazilClinical trials for the coronavirus vaccine being developed by AstraZeneca PLC and Oxford University resumed in Brazil on Monday after the country's health regulator got confirmation over the weekend that its British equivalent MHRA had approved the restart, a company representative...
Read more »